BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31203133)

  • 1. Long-term anesthetic analgesic effects: Comparison of tetracaine loaded polymeric nanoparticles, solid lipid nanoparticles, and nanostructured lipid carriers in vitro and in vivo.
    Liu X; Zhao Q
    Biomed Pharmacother; 2019 Sep; 117():109057. PubMed ID: 31203133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers.
    You P; Yuan R; Chen C
    Drug Des Devel Ther; 2017; 11():2743-2752. PubMed ID: 29075099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer.
    Yang Y; Qiu D; Liu Y; Chao L
    Drug Des Devel Ther; 2019; 13():3307-3319. PubMed ID: 31571832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy.
    Wang Y; Wang S; Shi P
    Drug Deliv; 2016 Nov; 23(9):3193-3199. PubMed ID: 27045388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation.
    Yue Y; Zhao D; Yin Q
    Biomed Pharmacother; 2018 Feb; 98():813-820. PubMed ID: 29571251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers.
    Chen Y; Zhou L; Yuan L; Zhang ZH; Liu X; Wu Q
    Int J Nanomedicine; 2012; 7():3023-32. PubMed ID: 22787398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system.
    Zhao X; Sun Y; Li Z
    Drug Des Devel Ther; 2018; 12():4231-4240. PubMed ID: 30587919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine and levobupivacaine co-loaded, transcriptional transactivator peptide modified nanostructured lipid carriers or lipid-polymer hybrid nanoparticles, which performed better for local anesthetic therapy?
    Li M; Feng S; Xing H; Sun Y
    Drug Deliv; 2020 Dec; 27(1):1452-1460. PubMed ID: 33100057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pre-formulation study of tetracaine loaded in optimized nanostructured lipid carriers.
    Castro SR; Ribeiro LNM; Breitkreitz MC; Guilherme VA; Rodrigues da Silva GH; Mitsutake H; Alcântara ACS; Yokaichiya F; Franco MKKD; Clemens D; Kent B; Lancellotti M; de Araújo DR; de Paula E
    Sci Rep; 2021 Nov; 11(1):21463. PubMed ID: 34728779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
    Wang W; Chen L; Huang X; Shao A
    AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
    Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K
    Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
    Dudhipala N; Janga KY; Gorre T
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local anesthetic lidocaine delivery system: chitosan and hyaluronic acid-modified layer-by-layer lipid nanoparticles.
    Zhang L; Wang J; Chi H; Wang S
    Drug Deliv; 2016 Nov; 23(9):3529-3537. PubMed ID: 27340888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An efficient and long-acting local anesthetic: ropivacaine-loaded lipid-polymer hybrid nanoparticles for the control of pain.
    Li A; Yang F; Xin J; Bai X
    Int J Nanomedicine; 2019; 14():913-920. PubMed ID: 30774342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination anesthetic therapy: co-delivery of ropivacaine and meloxicam using transcriptional transactivator peptide modified nanostructured lipid carriers
    Yuan S; Chen J; Feng S; Li M; Sun Y; Liu Y
    Drug Deliv; 2022 Dec; 29(1):263-269. PubMed ID: 35014916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.